GEL Properties subscribes with 10% OID; interest payable in stock
By Susanna Moon
Chicago, Sept. 17 - Northwest Biotherapeutics, Inc. sold an $833,333.33 4% two-year convertible promissory note to GEL Properties, LLC. The note includes an original issue discount of 10%. Interest is payable in common stock.
The holder may elect to convert all or part of the note into stock, beginning on March 11, 2013, at a conversion price of 90% of the market price at the time of conversion.
The company may prepay and redeem the note at any time upon five days written notice and upon payment of 150% of the unpaid principal amount of the note.
GEL also received 30% warrant coverage, with an exercise price of $0.40. The warrant will be exercisable for 624,999 shares during a five-year exercise period.
Northwest is a development-stage biotechnology company based in Bothell, Wash.
| Issuer: | Northwest Biotherapeutics, Inc.
|
| Issue: | Convertible promissory note
|
| Amount: | $833,333.33
|
| Maturity: | Sept. 11, 2014
|
| Coupon: | 4%
|
| Price: | 10% discount
|
| Call: | 150% of unpaid principal amount
|
| Conversion price: | At 90% of market price beginning March 11, 2013
|
| Warrants: | For 624,999 shares
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $0.40
|
| Settlement date: | Sept. 11
|
| Announcement date: | Sept. 17
|
| Stock symbol: | Pink sheets: NWBO
|
| Stock price: | $0.29 at close Sept. 14
|
| Market capitalization: | $48.89 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
